Medicine and Dentistry
Breast Cancer
100%
Neoplasm
81%
Breast Carcinoma
70%
Pathologist
69%
Cytotechnology
65%
Wart Virus
60%
Immunohistochemistry
49%
Papanicolaou Stain
49%
Epidermal Growth Factor Receptor 2
45%
Gamma Urogastrone
42%
Cytopathology
36%
Diagnosis
35%
Metastatic Carcinoma
32%
Fine-Needle Aspiration
30%
Recurrent Disease
27%
Triple Negative Breast Cancer
25%
Neoadjuvant Chemotherapy
25%
Digital Pathology
24%
Malignant Neoplasm
23%
Adenocarcinoma
23%
Biological Marker
23%
Programmed Death-Ligand 1
22%
Biopsy Technique
22%
Cervical Cancer
20%
Endometrium Carcinoma
19%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
19%
Estrogen Receptor
18%
Squamous Cell Carcinoma
18%
Uterine Cervix Cytology
17%
Cervical Intraepithelial Neoplasia
17%
Carcinoma
16%
Hormone Receptor
16%
Liquid-Based Cytology
16%
Tumor Cell
15%
Immunity
15%
Squamous Cell
15%
Cancer
14%
Fluorescence in Situ Hybridization
14%
Invasive Carcinoma
14%
Oncotype DX
14%
CD8 Antigen
13%
Tumor Infiltrating Lymphocyte
13%
Uterine Cervix Carcinoma
12%
Prevalence
12%
Uterine Cancer
11%
Adenocarcinoma in Situ
11%
Neuroendocrine Tumor
11%
Gene Mutation
11%
Morphology
10%
Transcription Factor GATA 3
10%
Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
59%
Breast Cancer
52%
Breast Carcinoma
50%
High-risk Human Papillomavirus (HR-HPV)
43%
Papanicolaou Test
41%
Pathologist
36%
Human Papillomavirus Testing
33%
Programmed Death-ligand 1 (PD-L1)
33%
Immunohistochemistry
33%
China
33%
College of American Pathologists
30%
Tumor
27%
Artificial Intelligence
27%
Cytopathology
27%
Digital Pathology
26%
Histopathologic Follow-up
23%
Whole-slide Imaging
23%
High-grade Squamous Intraepithelial Lesion
21%
Cervical Cytology
20%
Cytological Samples
20%
Fine-needle Aspiration
18%
Cervical Intraepithelial Neoplasia
18%
Atypical Glandular Cells
17%
Intratumoral Heterogeneity
16%
Squamous Cell Carcinoma (SqCC)
16%
Breast
15%
Carcinoma in Situ
15%
Triple-negative Breast Carcinoma
15%
Non-small Cell Lung Cancer (NSCLC)
15%
High-risk Human Papillomavirus Testing
15%
HPV Testing
15%
Reporting Rate
15%
Invasive Cervical Cancer
15%
Endometrial Carcinoma
15%
HER2-positive Breast Cancer
14%
Single Institution
14%
Fluorescence in Situ Hybridization
14%
Magee Equation
14%
Whole Slide Image
14%
Oncotype DX
13%
Liquid-based Cytology
13%
Invasive Carcinoma
13%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
13%
Core Needle Biopsy
13%
Estrogen Receptor
13%
Neoadjuvant Chemotherapy
13%
Pathological Diagnosis
12%
Triple Negative
12%
Human Papillomavirus Genotypes
12%
Image Cytometry
12%
